LinkedIn Live: Advancing Radioconjugate Therapeutics: Leveraging Kidney PTC Models for Predictive Uptake and Toxicity Assessment

Join us for our next LinkedIn Live event this month, where Dr Adam Pearson will be discussing “Advancing Radioconjugate Therapeutics: Leveraging Kidney PTC Models for Predictive Uptake and Toxicity Assessment”.

The talk will:

• Examine the use of in vitro kidney proximal tubule cell (PTC) models to assess renal uptake of radioconjugate therapeutics during early-stage development.
• Highlight key advancements in PTC model systems, that better replicate renal physiology and transport mechanisms relevant to radioconjugate exposure.
• Showcase case studies demonstrating how in vitro PTC assays support compound screening and preclinical safety assessment of radioconjugate compounds.

Speaker

Dr Adam Pearson, PhD – Scientist II – Newcells Biotech